Stephen A. Cannistra

Author

Beth Israel Deaconess Medical Center

Also Known As

S A Cannistra, S. A. Cannistra, Stephen A Cannistra, Stephen A. Cannistra, Stephen Cannistra, Stephen A. Cannistra

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Harvard University Massachusetts General Hospital Brigham and Women's Hospital

About

Stephen A. Cannistra is an author at Beth Israel Deaconess Medical Center specializing in medicine, oncology, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.5K
2	Health Sciences	2	2	80
3	Education	1	1	62
4	Law	1	1	62
5	Public Health	1	1	44

Stephen A. Cannistra

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Journal of Clinical Oncology	2007	754
Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression Karen Antman, James D. Griffin, Anthony Elias, New England Journal of Medicine	1988	684
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Beth Y. Karlan, Journal of Clinical Oncology	2010	485
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer Ursula A. Matulonis, Suzanne Berlin, Percy Ivy, Journal of Clinical Oncology	2009	300
Cancer of the Ovary Stephen A. Cannistra New England Journal of Medicine Endocrine-related CancerMalignant DiseaseMedicineGynecologyPathology	1993	293
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Elena Fountzilas, Cancer Research Platinum ResistanceOncologyKeap1 MutationsMedicineCancer Cell Biology	2011	265
Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer Dimitrios Spentzos, Douglas A. Levine, Marco Ramoni, Journal of Clinical Oncology	2004	257
Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian Carcinomas Keisuke Kurose, Xiao-Ping Zhou, Tsutomu Araki, American Journal Of Pathology MedicinePten ExpressionPathologyCyclin D1 ExpressionTumor Suppressor	2001	254
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway Thomas Ströbel, Linda J. Swanson, Stanley J. Korsmeyer, Proceedings of the National Academy of Sciences	1996	223
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer Joyce F. Liu, Christina I. Herold, Kathryn P. Gray, JAMA Oncology	2019	218

Page 1